CELLINK designs and develops bioprinting technologies that enable researchers to 3D print organs and tissue for applications that span industries, from pharmaceutical to cosmetic. Our patent-pending bioink is a biomaterial innovation that allows human cells to grow and thrive as they would in their natural environment. Researchers leverage our technologies to print liver, cartilage, skin tissues and more.

Combining persistence, passion and innovative excellence enabled CELLINK to catalyze and accelerate the genesis of the bioprinting industry. We optimized the path to commercialization to drive the advancement of bioprinting technologies from the lab to the clinic with unprecedented speed – transforming CELLINK into the globally recognized gold standard of pioneering cell cultivation systems in pharmaceutical research and drug development.